The Discounted Cash Flow (DCF) valuation of Balaxi Pharmaceuticals Ltd (BALAXI.NS) is 45.03 INR. With the latest stock price at 21.12 INR, the upside of Balaxi Pharmaceuticals Ltd based on DCF is 113.2%.
Based on the latest price of 21.12 INR and our DCF valuation, Balaxi Pharmaceuticals Ltd (BALAXI.NS) is a buy. buying BALAXI.NS stocks now will result in a potential gain of 113.2%.
| Range | Selected | |
| WACC / Discount Rate | 10.6% - 13.1% | 11.9% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 39.33 - 52.78 | 45.03 |
| Upside | 86.2% - 149.9% | 113.2% |